NCT06386185 Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography
| NCT ID | NCT06386185 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Royal United Hospitals Bath NHS Foundation Trust |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2024-09-06 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2024-09-06 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in echocardiography, and ECG have in detecting pulmonary hypertension. The main questions it aims to answer are: Can novel markers in ECG and echocardiography suggest the presence of PH? Can existing screening guidelines be improved with the addition of these markers?
Eligibility Criteria
Inclusion Criteria: * Patients 18+ who have undergone TTE, ECG and RHC as part of their clinical care Exclusion Criteria: * Patients \<18 years old * Known or suspected congenital heart disease * Patient has opted-out of allowing their data to be used for research and planning (via the national data opt-out choice in England, or equivalent data protection scheme in Scotland)
Contact & Investigator
Daniel X Augustine
PRINCIPAL INVESTIGATOR
Royal United Hospital
Frequently Asked Questions
Who can join the NCT06386185 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06386185 currently recruiting?
Yes, NCT06386185 is actively recruiting participants. Contact the research team at chris.wild1@nhs.net for enrollment information.
Where is the NCT06386185 trial being conducted?
This trial is being conducted at Bath, United Kingdom, Glasgow, United Kingdom, Sheffield, United Kingdom, Cambridge, United Kingdom and 1 additional location.
Who is sponsoring the NCT06386185 clinical trial?
NCT06386185 is sponsored by Royal United Hospitals Bath NHS Foundation Trust. The principal investigator is Daniel X Augustine at Royal United Hospital. The trial plans to enroll 2,500 participants.